Hirayama and Granuloma—The Affinity Saga

Abstract

Foreign-body granulomas secondary to synthetic materials used in neurosurgery are common. It has been reported that most of them occur after brain surgery than spinal surgery. Hirayama disease, which presents as a slow progressive upper limb muscle weakness and subsequently atrophy, obligates surgical intervention when the conservative management fails. It is managed by posterior cervical surgery followed by dural repair, while anterior cervical surgery is also an option. The component present in duroplasty material, ReDura, may cause exuberant granuloma formation. Foreign-body granuloma at the site of dural repair secondary to the synthetic dural component can cause spinal cord compression worsening the symptoms, requiring surgery. We hereby report a case of a young male with Hirayama disease who underwent posterior cervical surgery followed by duroplasty. The mass effect by the granuloma, secondary to dural repair, was relieved surgically and patient improved neurologically.

Keywords

Hirayama disease - granuloma formation - ReDura - posterior cervical techniques - MRI spine

Publikationsverlauf

Artikel online veröffentlicht:
01. Juli 2025

• References

• 1 Al-Hashel JY, Abdelnabi EA, Ibrahim Ismail I. Monomelic amyotrophy (Hirayama disease): a rare case report and literature review. Case Rep Neurol 2020; 12 (03) 291-298
• 2 Ekici MA, Ekici A, Per H, Tucer B, Kurtsoy A. Foreign body granuloma mimicking upper cervical spinal mass after dural repair with Tachocomb [correction of Tachocomp]: a case report. Pediatr Neurosurg 2010; 46 (02) 133-137
• 3 Wang H, Tian Y, Wu J. et al. Update on the pathogenesis, clinical diagnosis, and treatment of Hirayama disease. Front Neurol 2022; 12: 811943
• 4 Wang H, Tian Y, Wu J. et al. The radiological and electrophysiological characteristics of Hirayama disease with proximal involvement: a retrospective study. Front Neurol 2022; 13: 969484
• 5 Gomathy SB, Agarwal A, Garg A, Vishnu VY. Hirayama disease: review on pathophysiology, clinical features, diagnosis and treatment. US Neurol 2022; 18 (02) 109
• 6 Boruah DK, Prakash A, Gogoi BB, Yadav RR, Dhingani DD, Sarma B. The importance of flexion MRI in Hirayama disease with special reference to laminodural space measurements. AJNR Am J Neuroradiol 2018; 39 (05) 974-980
• 7 Xu H, Shao M, Zhang F. et al. Snake-eyes appearance on MRI occurs during the late stage of Hirayama disease and indicates poor prognosis. BioMed Res Int 2019; 2019: 9830243
• 8 Gao Y, Sun C, Ma X, Lu F, Jiang J, Wang H. Do patients with Hirayama disease require surgical treatment? A review of the literature. Intractable Rare Dis Res 2022; 11 (04) 173-179
• 9 Thakar S, Arun AA, Rajagopal N. et al. Outcomes after Cervical duraplasty for monomelic amyotrophy (Hirayama Disease): results of a case-control study of 60 patients. J Neurosci Rural Pract 2021; 12 (04) 642-651
• 10 Zenga F, Tardivo V, Pacca P, Garzaro M, Garbossa D, Ducati A. Nanofibrous synthetic dural patch for skull base defects: preliminary experience for reconstruction after extended endonasal approaches. J Neurol Surg Rep 2016; 77 (01) e50-e55
• 11 Mohammed K, Iqbal J, Arshad M. et al. Extensive foreign body reaction to synthetic dural replacement after decompressive craniectomy with radiological and histopathology evidence: observational case series. World Neurosurg 2023; 172: e585-e592
• 12 Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20 (02) 86-100